课题基金 / 基金详情

THE COMPARATIVE EFFECTIVENESS OF TELEMEDICINE TO DETECT DIABETIC RETINOPATHY

THE COMPARATIVE EFFECTIVENESS OF TELEMEDICINE TO DETECT DIABETIC RETINOPATHY
远程医疗检测糖尿病视网膜病变的比较效果
批准号:
8051941
负责人:
THOMAS MARK BECKER
金额:
$200.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-14 至 2013-04-13

项目摘要

项目成果

THOMAS MARK BECKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diabetic retinopathy is the leading cause of blindness in working-age adults, and both the disease and ensuing blindness disproportionately affect American Indians and Alaskan Natives (AI/AN). The Agency for Healthcare Research and Quality reported that annual diabetic eye exams would save the government an estimated $472 million dollars per year. The cornerstone of prevention of vision loss is annual eye exams and early treatment, but less than 50% of AI/AN diabetic patients receive annual eye exams. Among northwest AI/AN, only two of the 43 federally recognized tribes have affiliated clinicians who can provide yearly eye exams, and the long distance of many rural reservations from urban eye care centers complicates routine care for diabetic retinopathy. This proposal will address three critical gaps in knowledge: 1) the efficacy for detecting diabetic retinopathy with telemedicine and traditional surveillance methods; 2) the health behavior factors related to receiving annual diabetic eye examinations with telemedicine and traditional surveillance methods; and 3) the cost-effectiveness of telemedicine and traditional surveillance methods. The impact of this project will be large if we can achieve even a small increase in the proportion of patients receiving eye exams. This benefit increases further if we show an increase in cost-effectiveness and sensitivity to detecting diabetic retinopathy. Future experiences and data from this project will provide the framework for changes in the national and statewide guidelines in the delivery of diabetic eye exams as well as a larger randomized clinical trial. Our research group's expertise, track record, and established relationships make us uniquely positioned to address these gaps in knowledge to prevent blindness from diabetic retinopathy.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ophtha.2013.12.016
发表时间: 2014-06
期刊: Ophthalmology
影响因子: 13.7
作者: [Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL]
通讯作者: Mansberger SL
Administrative Core
Forging our Futures: Studying Science to Protect Tribal Health
Strengthening Indigenous Health and Science Research: NW NARCH Program
Research Fellowships for NW Tribal Population Health Sciences Students
海外基金